Opendata, web and dolomites

GLADIATOR SIGNED

Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GLADIATOR project word cloud

Explore the words cloud of the GLADIATOR project. It provides you a very rough idea of what is the project "GLADIATOR" about.

stimulation    therapeuticdiagnostic    drastic    underlying    revolutionary    prototype    anticipated    release    network    clinically    conceptual    industry    faceted    detrimental    ecmc    brain    appropriate    communication    time    supra    radical    establishes    host    internet    delivering    evolution    stem    societal    interventions    generate    bridging    malignancies    sub    nano    platform    life    rationally    grim    applicable    progress    components    optoelectronic    emergence    communications    vision    cellular    sensors    interfering    spatiotemporal    wireless    cancer    engineered    implantable    diagnostics    nanotechnology    autonomously    intervention    prognosis    micro    therapeutic    bio    electronic    transforming    solution    externally    proof    tumour    cell    breakthrough    cells    shift    ushering    autonomous    ict    theranostic    tumours    demand    mirnas    pathologies    hybrid    consisting    engineering    socioeconomic    complete    interface    therapy    promises    biological    sciences    insc    reprogramming    monitor    environment    despite    inscs    exosomal    nanonetworks    organoids    molecular    first    recurrence    autologous    radiofrequency    things    framework    gladiator    burgeoning    vanguard    discipline    renewal    designed    fluorescent    nanomachines    coupled    glioblastoma    external    neural    nanonetwork    paradigm    channels    nanomachine    disorders    multiforme    building    oncology   

Project "GLADIATOR" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF CYPRUS 

Organization address
address: KALLIPOLEOS STREET 75
city: NICOSIA
postcode: 1678
website: www.ucy.ac.cy

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Cyprus [CY]
 Total cost 6˙122˙255 €
 EC max contribution 5˙982˙255 € (98%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF CYPRUS CY (NICOSIA) coordinator 953˙125.00
2    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) participant 1˙758˙103.00
3    E.P.O.S. IASIS RESEARCH AND DEVELOPMENT LTD CY (LEFKOSIA) participant 1˙111˙540.00
4    OULUN YLIOPISTO FI (OULU) participant 950˙535.00
5    NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU NO (TRONDHEIM) participant 787˙076.00
6    WATERFORD INSTITUTE OF TECHNOLOGY IE (Waterford) participant 421˙875.00
7    OSAKA UNIVERSITY JP (OSAKA) participant 0.00

Map

 Project objective

Brain pathologies are highly complex disorders. Despite recent progress, their prognosis is grim, defining a high societal challenge. Bridging life sciences, bio-nanotechnology, engineering and ICT, GLADIATOR promises a vanguard and comprehensive theranostic (therapeuticdiagnostic) solution for brain malignancies. Through a multi-faceted breakthrough, GLADIATOR will provide, for the first time, a working prototype of a complete, autonomous and clinically applicable, nanonetwork-based, Molecular Communications system based on the conceptual framework of Externally Controllable Molecular Communications (ECMC). Using Glioblastoma Multiforme tumours, the most detrimental brain pathologies, as a proof-of-concept case, GLADIATOR will implement a platform of cell-based and electronic components. Implantable autologous organoids of engineered neural stem cells (iNSCs) will release rationally designed exosomal bio-nanomachines, delivering reprogramming (therapeutic) miRNAs and building nanonetworks. Interfering with the underlying biological environment, the nanonetworks will define a revolutionary intervention. A hybrid bio-electronic interface, consisting of coupled external and implantable devices, will enable communication channels with host-derived fluorescent bio-nanomachines via micro-optoelectronic sensors. The cellular, sub-cellular and electronic components will be integrated into a wireless ECMC network. This system will autonomously monitor the spatiotemporal tumour evolution and recurrence and generate, on demand, appropriate reprogramming interventions, by radiofrequency stimulation of iNSC renewal. A paradigm shift in Oncology Research is anticipated via the supra-discipline of “bio-nanomachine diagnostics”. GLADIATOR establishes a radical long-term vision leading to a drastic change in cancer therapy, also ushering the emergence of the ECMC field and transforming the burgeoning industry of Internet of Nano-bio-things, with high socioeconomic impact.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLADIATOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLADIATOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

SHERO (2019)

Self-HEaling soft RObotics

Read More  

LABELFREE (2019)

LABEL FREE IMAGING WITH PHI-SCAT

Read More